SALICYLIC ACID solution

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)

Доступна з:

KMM Pharmaceuticals, LLC

Адміністрація маршрут:

TOPICAL

Тип рецепту:

PRESCRIPTION DRUG

Терапевтичні свідчення:

This product is indicated for the topical treatment and removal of common warts and plantar warts. This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. Patients with diabetes or impaired blood circulation should not use this product. This product also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. This product should not be allowed to contact normal skin surrounding the wart site, since localized irritation may occur. Treatment should be discontinued if excessive irritation occurs.

Огляд продуктів:

1/3 fl. oz. (10 mL) bottles, NDC 52187-522-10 Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing and excessive heat. Keep bottle tightly closed. Manufactured for: KMM Pharmaceuticals, LLC 1000 N. West Street Suite 1200, #1021 Wilmington, DE 19801 v1 Rev 07/2017 827545

Статус Авторизація:

unapproved drug other

Характеристики продукта

SALICYLIC ACID- SALICYLIC ACID SOLUTION
KMM PHARMACEUTICALS, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
SALICYLIC ACID 28.5% SOLUTION
SALICYLIC ACID 28.5% SOLUTION (SALICYLIC ACID 28.5% EXTENDED RELEASE)
RX ONLY
FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
DESCRIPTION:
Each mL contains 285 mg of salicylic acid extended release in a
film-forming virucidal solution
consisting of acrylates copolymer, isopropyl alcohol, n-Butyl acetate,
polyvinyl butyral, and trimethyl
pentanyl diisobutyrate.
The pharmacologic activity of this product is generally attributed to
the keratolytic activity of salicylic
acid, which is incorporated into a polyacrylic, film-forming virucidal
solution designed to cover the
wart without the need for a bandage. The structural formula of
salicylic acid is:
CLINICAL PHARMACOLOGY:
Although the exact mode of action for salicylic acid in the treatment
of warts is unknown, its activity
appears to be associated with its keratolytic action, which results in
mechanical removal of epidermal
cells infected with wart viruses.
INDICATIONS AND USAGE:
This product is indicated for the topical treatment and removal of
common warts and plantar warts.
CONTRAINDICATIONS:
This product is contraindicated in persons with known or suspected
hypersensitivity to any of the
ingredients of the product. Patients with diabetes or impaired blood
circulation should not use this
product. This product also should not be used on moles, birthmarks,
and unusual warts with hair
growing from them, or warts on the face.
WARNINGS: KEEP OUT OF REACH OF CHILDREN.
This product is flammable. Keep away from fire or flame. Keep bottle
tightly closed when not in use.
PRECAUTIONS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
If contact with eyes or mucous membranes occurs, immediately flush
with water for 15 minutes. This
product should not be allowed to contact normal skin surroun